Browse by ["viewname_eprint_publisher" not defined]
![]() | Up a level |
- University of Regensburg (10)
- Medicine (10)
- Lehrstuhl für Dermatologie und Venerologie (10)
- Medicine (10)
B
Brueggemann, Caroline and Weide, Benjamin and Goldinger, Simone M. and Konrad, Andreas and Erdmann, Michael and Schadendorf, Dirk and Croner, Roland S. and Kraehenbuehl, Lukas and Kaehler, Katharina C. and Hafner, Christian and Leisgang, Waltraud and Kiesewetter, Franklin and Dummer, Reinhard and Schuler, Gerold and Stuerzl, Michael and Heinzerling, Lucie (2015) Association of PD-L1 expression in melanoma with response and prognosis to ipilimumab. JOURNAL OF CLINICAL ONCOLOGY, 33 (15supp): 9044. ISSN 0732-183X, 1527-7755
E
Eigentler, Thomas K. and Gutzmer, Ralf and Hauschild, Axel and Kaempgen, Eckhart and Schadendorf, Dirk and Nashan, Dorothee and Hoelzle, Erhard and Trefzer, Uwe and Becker, Juergen C. and Sunderkoetter, Cord and Moll, Ingrid and Richtig, Erika and Poenitzsch, Iris and Pehamberger, Hubert and Kaufmann, Roland and Pfoehler, Claudia and Vogt, Thomas and Berking, Carola and Praxmarer, Michael and Garbe, Claus (2014) Adjuvant therapy with pegylated interferon alfa-2a (PEG-IFN) versus low-dose interferon alfa-2a (IFN) in patients with malignant melanoma in stages IIa(T3a): IIIb (AJCC 2002)-Decog-trial. JOURNAL OF CLINICAL ONCOLOGY, 32 (15supp): 9071. ISSN 0732-183X, 1527-7755
G
Grob, J. J. and Jouary, T. and Dreno, B. and Gutzmer, R. and Hauschild, A. and Leccia, M. T. and Landthaler, M. and Asselineau, J. and Garbe, C. and Pehamberger, H. E. (2010) Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macro-metastatic nodes: EADO trial. JOURNAL OF CLINICAL ONCOLOGY, 28 (18supp): LBA8506. ISSN 0732-183X, 1527-7755
H
Harbeck, N. and Hadji, P. and Jackisch, C. and Landthaler, M. and Heilmann, V. and Baier, B. and Blettner, M. and Lueck, H. and von Fircks, A. Rexrodt and Kreienberg, R. (2010) First results from the Patient's Anastrozole Compliance to Therapy (PACT) program evaluating the influence of a standardized information service on compliance in postmenopausal women with early breast cancer (EBC). JOURNAL OF CLINICAL ONCOLOGY, 28 (15supp). ISSN 0732-183X, 1527-7755
Hauschild, Axel and Weichenthal, Michael and Rass, Knuth and Linse, Ruthild and Berking, Carola and Boettjer, Joerg and Vogt, Thomas and Spieth, Konstanze and Eigentler, Thomas and Brockmeyer, Norbert H. and Stein, Annette and Naeher, Helmut and Schadendorf, Dirk and Mohr, Peter and Kaatz, Martin and Tronnier, Michael and Hein, Ruediger and Schuler, Gerold and Egberts, Friederike and Garbe, Claus (2010) Efficacy of Low-Dose Interferon alpha 2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of >= 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial. JOURNAL OF CLINICAL ONCOLOGY, 28 (5). pp. 841-846. ISSN 0732-183X
Hauschild, Axel and Weichenthal, Michael and Rass, Knuth and Linse, Ruthild and Ulrich, Jens and Stadler, Rudolf and Volkenandt, Matthias and Grabbe, Stephan and Proske, Ulrike and Schadendorf, Dirk and Brockmeyer, Norbert and Vogt, Thomas and Rompel, Rainer and Kaufmann, Roland and Kaatz, Martin and Naeher, Helmut and Mohr, Peter and Eigentler, Thomas and Livingstone, Elisabeth and Garbe, Claus (2009) Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-Dose Interferon Alfa-2b With or Without a Modified High-Dose Interferon Alfa-2b Induction Phase in Patients With Lymph Node-Negative Melanoma. JOURNAL OF CLINICAL ONCOLOGY, 27 (21). pp. 3496-3502. ISSN 0732-183X
L
Leiter, Ulrike and Stadler, Rudolf and Mauch, Cornelia and Hohenberger, Werner and Brockmeyer, Norbert and Berking, Carola and Sunderkoetter, Cord and Kaatz, Martin and Schulte, Klaus-Werner and Lehmann, Percy and Vogt, Thomas and Ulrich, Jens and Herbst, Rudolf and Gehring, Wolfgang and Simon, Jan-Christoph and Keim, Ulrike and Garbe, Claus (2015) Survival of SLNB-positive melanoma patients with and without complete lymph node dissection: A multicenter, randomized DECOG trial. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.
Leiter, Ulrike and Stadler, Rudolf and Mauch, Cornelia and Hohenberger, Werner and Brockmeyer, Norbert and Berking, Carola and Sunderkoetter, Cord and Kaatz, Martin and Schulte, Klaus-Werner and Lehmann, Percy and Vogt, Thomas and Ulrich, Jens and Herbst, Rudolf and Gehring, Wolfgang and Simon, Jan-Christoph and Keim, Ulrike and Garbe, Claus (2015) Survival of SLNB-positive melanoma patients with and without complete lymph node dissection: A multicenter, randomized DECOG trial. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.
S
Storey, Lucy and Abdul-Latif, Mohammed and Kreft, Sophia and Barrett, Emma and Pickering, Lisa M. and Rohaan, Maartje W. and Ahmed, Sobia and Eigentler, Thomas K. and Hassel, Jessica Cecile and Haferkamp, Sebastian and Meiss, Frank and Steeb, Theresa and Shaw, Heather May and Blank, Christian U. and Van Akkooi, Alexander Christopher Jonathan and Larkin, James M. G. and Schilling, Bastian and Lorigan, Paul and Nathan, Paul D. (2020) Checkpoint inhibitor treatment in patients with isolated in-transit melanoma metastases. In: 2020 ASCO Annual Meeting I - Virtual Scientific Program.
W
Weichenthal, Michael and Ugurel, Selma and Leiter, Ulrike M. and Satzger, Imke and Kaehler, Katharina C. and Welzel, Julia and Pfoehler, Claudia and Feldmann-Boeddeker, Ingrid and Meier, Friedegund Elke and Terheyden, Patrick and Haferkamp, Sebastian and Herbst, Rudolf and Ulrich, Jens and Utikal, Jochen and Kreuter, Alexander and Gutzmer, Ralf and Schadendorf, Dirk and Mohr, Peter (2019) Salvage therapy after failure from anti-PD-1 single agent treatment: A Study by the German ADOReg melanoma registry. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.

